Eli Lilly and Company (LLY) — closed signal from May 27, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 25, 2026.
Predicted vs. what happened
LLY price · publication thesis → realized outcomesplit-adjusted
$1,025.00 – $1,070.00Entry zone — fair-value band
$1,081.97Published — price the day we called it
$1,190.16Target — the price the thesis aimed for
$1,292.65Peak — highest point inside the window, not a realized return
$1,233.66Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 30 days.
Peak price
$1,292.65
peak on August 19, 2026 — not a realized returnPeak gain
+19.5%
peak, from the publication priceWindow close
$1,233.66
end-of-window price, context onlyDays to target
30
Window
May 27, 2026 – August 25, 2026
The thesis — published May 27, 2026
Predicted growth
+10%
over the measurement windowTarget price
$1,190.16
the price the thesis aimed forEntry zone
$1,025.00 – $1,070.00
the fair-value band we waited forPrice at publication
$1,081.97
published May 27, 2026Confidence
70%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Eli Lilly is a high-quality healthcare growth company driven by its obesity and diabetes businesses and a deep pipeline. New retatrutide results made the long-term medical story stronger and kept investor focus on next-generation incretin drugs. Near-term risk is higher because the stock is trading above preferred levels and volume is light.
Primary drivers
- Retatrutide results boost confidence in next-wave obesity drugs
- Diabetes and obesity franchises make earnings more predictable
- Large, diverse pipeline supports sustained healthcare growth
- Current pricing and light volume mean patience and price discipline matter
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.